BRIC/Finsen Group leaders will be part of national brain cancer center
The Danish Cancer Society has given 20 million DKK to a national Cancer Research Center for Targeted treatment of Primary Brain Tumors. The centre will strengthen the ties between research and clinical practice and secure better treatment for patients with brain cancers. Several group leaders from BRIC/Finsen will be part of the new centre: Joachim Weischenfeldt, Kristian Helin, Krister Wennerberg, Janine Erler, Niels Behrendt and Lars Engelholm. Leader of the new centre is Ulrik Lassen, professor in clinical oncology and personal medicin and Head Physician at the oncology department at Rigshospitalet.
The centre will include a range of research projects ranging from clinical projects to basic research projects focused on the biology behind brain cancer. To begin with, the centre will focus on adult patients suffering from the aggressive type of brain cancer known as Glioblastoma, but later on the centre will also broaden its focus to include other types of brain cancer. Among the BRIC/Finsen group leaders involved in the centre is Group Leader Joachim Weischenfeldt:
“The main purpose of the centre is to bring research closer to the clinic and to standardize treatment throughout the country. Currently there are very limited treatment options for patients with brain tumors and we hope to change that with the centre that will include both basic and clinical research. I expect that the centre will bring us much closer to the everyday of the clinic– which I anticipate will enable a better and faster implementation of new research - to the benefit of the patients”. Joachim Weischenfeldt
The new centre currently has 20 research projects planned ranging from better diagnostics, better treatments and development and testing of new treatments based on the knowledge of cancer biology.